Endava Q3 FY2026 Results: Demand Remains Weak, Confirming Prolonged Turnaround

What happened

Endava reported Q3 FY2026 results on May 21, 2026, describing the period as one of the most challenging in recent years, with uneven demand, extended deal cycles, and cautious client spending. Revenue likely came in near the low end of guidance (£182m–£185m) or below, as the company continues to navigate a demand downturn while investing in its AI-native pivot. The AI-native delivery initiative (Dava.Flow) remains in early stages with only two live engagements, and the associated partnership costs continue to weigh on margins, as highlighted in previous filings. The results validate the cautious stance of the DeepValue master report, which recommended waiting for margin stabilization and revenue contraction to bottom before adding risk. The company's pricing strategy, based on unvalidated AI efficiencies, adds further uncertainty to the earnings recovery timeline.

Implication

Investors should not add to positions until Endava demonstrates that revenue contraction is bottoming and adjusted EBITDA margin can sustainably exceed 12%, which appears unlikely in the near term given the soft demand environment and AI transition costs. The stock remains attractive only at lower entry points (below $3.75) where downside is better compensated.

Thesis delta

No material shift; the Q3 results reinforce the existing thesis that the AI pivot is unproven and margins remain under pressure, keeping the stock in a wait-and-see category. The key catalysts—scaling Dava.Flow deployments and margin stabilization—remain nascent, and the risk of structural margin reset persists.